Here's your full detailed Selank page rewrite, ready to paste:
Selank — Full Product Page (Detailed Version)
Product Title:
Selank — Synthetic Tuftsin-Derived Heptapeptide Neuromodulatory Research Compound
Short Description:
A synthetically produced heptapeptide derived from the endogenous immune peptide tuftsin, investigated in preclinical research for neurochemical signaling pathway dynamics, GABAergic neurotransmission modeling, gene expression modulation research, and neuroimmune pathway regulation investigation in controlled laboratory settings. ≥99% Purity, HPLC-Verified. Third-Party CoA Included. For in-vitro laboratory research use only.
Full Product Description:
Overview
Selank is a synthetically produced heptapeptide derived from the endogenous immune peptide tuftsin. Within controlled laboratory research settings, Selank is employed as a molecular research tool to study neurochemical signaling pathway dynamics, gene expression modulation, and peptide-driven regulation of neuroimmune and neuroendocrine pathways. Experimental investigations typically focus on its biochemical behavior in controlled cellular assays and nonclinical animal research models.
Biochemical Characteristics
- Peptide Sequence: Thr–Lys–Pro–Arg–Pro–Gly–Pro
- Molecular Formula: C₃₃H₅₇N₁₁O₉
- Molecular Weight: 751.87 g/mol
- CAS Number: 129954-34-3
- Alternate Name: Selanc
Research Applications
In preclinical research environments, Selank is utilized to explore peptide-mediated modulation of intracellular signaling networks. Common experimental applications include:
Gene Expression Profiling Research
Profiling gene expression patterns linked to neurotransmitter-associated signaling pathways in controlled cell-based and animal research systems.
GABAergic Signaling Component Research
Examination of GABAergic signaling component dynamics in rodent neural tissue under defined experimental laboratory conditions.
Enkephalin-Degrading Enzyme Activity Research
Biochemical assessment of enkephalin-degrading enzyme activity and associated endogenous peptide turnover pathway dynamics in controlled research settings.
Immune-Related Transcriptional Response Investigation
Investigation of immune-related transcriptional response dynamics involving cytokine and chemokine signaling pathway endpoints in controlled experimental systems.
Peptide Stability & Receptor Signaling Research
Evaluation of peptide stability parameters and receptor-associated signaling behavior in controlled in-vitro research environments.
Pathway & Mechanistic Context
Mechanistic studies document Selank's influence across intracellular signaling cascades associated with several key neurobiological and immune research frameworks:
GABAergic Neurotransmission Pathway Research
In controlled animal research models, Selank exposure has been correlated with changes in expression patterns of genes involved in GABAergic receptor signaling, providing a mechanistic framework for neurotransmission pathway investigation.
Monoaminergic Regulation Research
Documented associations between Selank exposure and monoaminergic pathway regulation dynamics in controlled preclinical research systems support its application in neurotransmitter signaling research paradigms.
Immune-Related Gene Transcription Research
Selank-associated modulation of immune-related gene transcription pathways — including cytokine-mediated cellular communication dynamics and inflammatory signaling endpoint markers — has been documented in controlled animal and cell-based research systems.
Enkephalinase Activity Modulation
Additional research has examined Selank-associated modulation of enkephalinase activity in controlled laboratory settings, indicating a potential indirect influence on endogenous peptide turnover and receptor-ligand availability at the molecular level under defined experimental conditions.
Preclinical Research Summary
Preclinical investigations involving Selank have primarily employed rodent research models and in-vitro biochemical systems. Published findings describe alterations in transcriptional profiles across neural and immune tissue samples, including genes related to:
- Inflammatory signaling pathway dynamics and cytokine-mediated communication endpoints
- Neurotransmitter receptor regulation and GABAergic signaling component activity
- Stress-responsive molecular pathway dynamics under defined experimental conditions
- Enzymatic processing pathway activity and endogenous peptide turnover mechanisms
- Neuroimmune gene network regulation and pathway-level signaling dynamics
Animal-based studies have further positioned Selank as a molecular research tool for examining peptide-driven regulation of neuroimmune gene networks, with an emphasis on pathway-level signaling insights rather than organism-level physiological outcome measurement. All findings are derived exclusively from controlled preclinical research systems and do not represent clinical outcomes of any kind.
Form & Analytical Characterization
Selank is supplied as a synthetic peptide for controlled laboratory research use. Analytical verification is conducted using:
- HPLC — peptide identity confirmation and purity profiling
- Mass Spectrometry (MS) — molecular mass confirmation and compound identity verification
These analytical controls support reproducibility and consistency across laboratory research workflows.
Purity & Quality
- ≥99% Purity — HPLC Verified
- Independently tested by accredited third-party laboratory
- Certificate of Analysis (CoA) available for every batch
Research Use Only (RUO) Notice
All products are furnished strictly for in-vitro laboratory research use only. These materials are not medicines or drugs and have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) to diagnose, treat, cure, or prevent any disease or medical condition. Administration into humans or animals is strictly prohibited. Not for human, medical, diagnostic, or veterinary use.
